Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes

PURPOSE: To investigate the efficacy, safety, and anatomical outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) treatment of retinopathy of prematurity (ROP). METHODS: We performed a retrospective review of intravitreal anti-VEGF (bevacizumab or ranibizumab) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyun Goo, Choi, Eun Young, Byeon, Suk Ho, Kim, Sung Soo, Koh, Hyoung Jun, Lee, Sung Chul, Kim, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288015/
https://www.ncbi.nlm.nih.gov/pubmed/30549468
http://dx.doi.org/10.3341/kjo.2018.0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288015/
https://www.ncbi.nlm.nih.gov/pubmed/30549468
http://dx.doi.org/10.3341/kjo.2018.0011

Ejemplares similares